Clinical Trial Update: Apatinib Plus Radiotherapy for Patients With Brain Metastases From Non-small-cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the combination of apatinib with radiotherapy for brain metastases in patients with non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Shanxi Province Cancer Hospital | Conditions: Brain Metastases | Phase 2 | Status: UNKNOWN